World's Best Scientists 2026 revealed!
Jean Michon

Jean Michon

D-Index & Metrics

Medicine

D-Index
76
Citations
20219
World Ranking
18815
National Ranking
629

Jean Michon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jean Michon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 296 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jean Michon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jean Michon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jean Michon is affiliated with the Institute Curie in France and has contributed to the field of medicine with a focus on oncology and related subfields. Their research covers surgery, neurology, epidemiology, general health professions, and health. The scientist's work encompasses various topics including vaccine coverage and hesitancy, neuroblastoma research and treatments, hepatitis B virus studies, hepatitis viruses studies and epidemiology, lung cancer research, cancer therapeutics and mechanisms, and lymphoma diagnosis and treatment.

Their frequent publication venues include:

  • Médecine et Maladies Infectieuses Formation
  • Médecine et Maladies Infectieuses
  • Pediatric Blood & Cancer
  • Cancers
  • Journal of Clinical Oncology

Co-authorship is notable with several researchers, including Aurélie Baldolli, Renaud Verdon, Ruth Ladenstein, Ulrike Pötschger, and Dominique Valteau-Couanet, reflecting collaboration across closely related studies and clinical investigations.

Recent papers by Jean Michon demonstrate involvement in multiple aspects of oncology research:

  • Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1), 2020, published in Cancers
  • Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group, 2020, published in Journal of Clinical Oncology
  • Relationships Between Managerial and Organizational Practices, Psychological Health at Work, and Quality of Care in Pediatric Oncology, 2020, published in JCO Oncology Practice
  • Patient management in pediatric oncology during the COVID-19 pandemic: Report from francophone Africa, 2020, published in Pediatric Blood & Cancer
  • In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure, 2020, published in Blood Advances

Jean Michon's research participation indicates a multidisciplinary approach combining clinical trials, patient management strategies, and epidemiological studies. The integration of studies on vaccine hesitancy and infectious diseases alongside cancer therapeutics illustrates a broad scope within medical research.

Best Publications

  • Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

    Isabelle Janoueix-Lerosey;Delphine Lequin;Delphine Lequin;Laurence Brugières;Agnès Ribeiro

  • The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

    Catherine Patte;Anne Auperin;Jean Michon;Henk Behrendt

  • Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Nathalie Gaspar;Douglas S. Hawkins;Uta Dirksen;Ian J. Lewis

  • Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

    Ruth Ladenstein;Ulrike Pötschger;Marie Cécile Le Deley;Jeremy Whelan

  • Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

    Catherine Patte;Anne Auperin;Mary Gerrard;Jean Michon

  • Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

    Thomas F Eleveld;Derek A Oldridge;Virginie Bernard;Jan Koster

  • A new member of the ETS family fused to EWS in Ewing tumors

    Martine Peter;Jérome Couturier;Hélène Pacquement;Jean Michon

  • Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

    Franck Tirode;Didier Surdez;Xiaotu Ma;Matthew Parker

  • Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

    Mitchell S. Cairo;Mary Gerrard;Richard Sposto;Anne Auperin

  • Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma

    Isabelle Janoueix-Lerosey;Gudrun Schleiermacher;Evi Michels;Véronique Mosseri

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial

    Christine Juergens;Claire Weston;Ian J. Lewis;Jeremy Whelan

  • Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

    Ruth Ladenstein;Ulrike Pötschger;Dominique Valteau-Couanet;Roberto Luksch

  • Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs: A Randomized, Controlled Trial

    Olivier Hartmann;Anne Gaelle Le Corroller;Didier Blaise;Jean Michon

  • N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.

    H Rubie;O Hartmann;J Michon;D Frappaz

  • Criteria for evaluation of disease extent by 123 I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

    K. K Matthay;B Shulkin;R Ladenstein;J Michon

  • Ovarian function after bone marrow transplantation during childhood.

    E Thibaud;K Rodriguez-Macias;C Trivin;H Espérou

  • Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

    Ruth Ladenstein;T. Philip;C. Lasset;O. Hartmann

  • Emergence of New ALK Mutations at Relapse of Neuroblastoma

    Gudrun Schleiermacher;Niloufar Javanmardi;Virginie Bernard;Quentin Leroy

  • Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group.

    Giovanni Cecchetto;Veronique Mosseri;Bruno De Bernardi;Pierre Helardot

Frequent Co-Authors

Olivier Delattre
Olivier Delattre PSL University
François Doz
François Doz Université Paris Cité
Odile Oberlin
Odile Oberlin Institut Gustave Roussy
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Eric Bouffet
Eric Bouffet University of Toronto
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Laurence Brugières
Laurence Brugières Institut Gustave Roussy
Genevieve Laureys
Genevieve Laureys Ghent University Hospital
André Baruchel
André Baruchel Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond studying Medicine in the USA, there are diverse online education and career pathways within healthcare. Those interested in managing patient data and records can consider an online health information management degree, which prepares graduates for vital roles in medical data systems.

For individuals seeking administrative positions, an online medical billing and coding certification is a popular, flexible option. These roles are essential in ensuring accurate billing and financial health for medical practices and hospitals.

Nursing is another dynamic field with a range of advancement opportunities. Aspiring nurse practitioners can explore the most cheapest fnp programs online, often designed for working professionals seeking higher credentials.

Additionally, pursuing the cheapest online msn programs allows registered nurses to earn a Master of Science in Nursing, expanding their scope of practice and leadership potential.

Best Scientists Citing Jean Michon

Trending Scientists